Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Willekens

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Journal of Immunology Research|October 6, 2016
Immunomodulatory Effects of 1,25-Dihydroxyvitamin D<sub>3</sub> on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived AntigensWai-Ping Lee, Barbara Willekens, Patrick Cras, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 19, 2021
Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic ReviewAbdu Kisekka Musubire, Judith Derdelinckx, Tatjana Reynders, et al.
Multiple Sclerosis and Related Disorders|July 9, 2022
Lifestyle factors in multiple sclerosis disability progression and silent brain damage: A cross-sectional studyLiesbeth Van Hijfte, Griet Loret, Helen Bachmann, et al.
Innate Immunity|April 3, 2016
Altered molecular expression of TLR-signaling pathways affects the steady-state release of IL-12p70 and IFN-α in patients with relapsing-remitting multiple sclerosisNathalie Deckx, Barbara Willekens, Inez Wens, et al.
BMC Nursing|January 28, 2025
Multiple Sclerosis Nursing to Improve Care and Education (MSNICE): an observational studyLiesbeth Van Hijfte, Melissa Cambron, Roel Crols, et al.
BMC Neurology|June 23, 2021
Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experienceMarie D'hooghe, Barbara Willekens, Valerie Delvaux, et al.
International Journal of Rehabilitation Research. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale De Recherches De Readaptation|May 17, 2016
The effectiveness of a self-management occupational therapy intervention on activity performance in individuals with multiple sclerosis-related fatigue: a randomized-controlled trialDaphne Kos, Marijke Duportail, Jill Meirte, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 21, 2019
Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trialMelissa Cambron, Jop Mostert, Marie D'Hooghe, et al.
Cells|December 22, 2020
HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis PatientsJudith Derdelinckx, Irene Nkansah, Naomi Ooms, et al.
Multiple Sclerosis and Related Disorders|April 13, 2018
Improving fatigue in multiple sclerosis by smartphone-supported energy management: The MS TeleCoach feasibility studyMarie D'hooghe, Geert Van Gassen, Daphne Kos, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Journal of Immunology Research|October 6, 2016
Immunomodulatory Effects of 1,25-Dihydroxyvitamin D<sub>3</sub> on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived AntigensWai-Ping Lee, Barbara Willekens, Patrick Cras, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 19, 2021
Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic ReviewAbdu Kisekka Musubire, Judith Derdelinckx, Tatjana Reynders, et al.
Multiple Sclerosis and Related Disorders|July 9, 2022
Lifestyle factors in multiple sclerosis disability progression and silent brain damage: A cross-sectional studyLiesbeth Van Hijfte, Griet Loret, Helen Bachmann, et al.
Innate Immunity|April 3, 2016
Altered molecular expression of TLR-signaling pathways affects the steady-state release of IL-12p70 and IFN-α in patients with relapsing-remitting multiple sclerosisNathalie Deckx, Barbara Willekens, Inez Wens, et al.
BMC Nursing|January 28, 2025
Multiple Sclerosis Nursing to Improve Care and Education (MSNICE): an observational studyLiesbeth Van Hijfte, Melissa Cambron, Roel Crols, et al.
BMC Neurology|June 23, 2021
Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experienceMarie D'hooghe, Barbara Willekens, Valerie Delvaux, et al.
International Journal of Rehabilitation Research. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale De Recherches De Readaptation|May 17, 2016
The effectiveness of a self-management occupational therapy intervention on activity performance in individuals with multiple sclerosis-related fatigue: a randomized-controlled trialDaphne Kos, Marijke Duportail, Jill Meirte, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 21, 2019
Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trialMelissa Cambron, Jop Mostert, Marie D'Hooghe, et al.
Cells|December 22, 2020
HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis PatientsJudith Derdelinckx, Irene Nkansah, Naomi Ooms, et al.
Multiple Sclerosis and Related Disorders|April 13, 2018
Improving fatigue in multiple sclerosis by smartphone-supported energy management: The MS TeleCoach feasibility studyMarie D'hooghe, Geert Van Gassen, Daphne Kos, et al.
Pageof 8